New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
09:06 EDTCICigna could divest VADBe business, says Credit Suisse
Credit Suisse believes Cigna could divest its Variable Annuity Death Benefit business, or VADBe, given the complexities of understanding the business and the constraint on valuation. The analyst believes an exit is increasingly likely given a recent transaction in the space, increased interest by buyers, and improved equity markets. The firm believes a divestiture would increase Cigna's multiple and reiterates its Outperform rating and $28 price target.
News For CI From The Last 14 Days
Check below for free stories on CI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 19, 2014
06:49 EDTCIGovernment says 7.3M in private Obamacare plans, NY Times reports
Subscribe for More Information
September 17, 2014
10:00 EDTCIOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.
08:38 EDTCICigna upgraded to Positive from Neutral at Susquehanna
As previously reported, Susquehanna upgraded Cigna to Positive from Neutral. The firm believes Cigna's earnings are poised to accelerate driven by a reduction in ACA related losses, conservative medical cost ratio assumptions, buybacks, and normal business growth. Price target raised to $115 from $77.
07:06 EDTCICigna upgraded to Positive from Neutral at Susquehanna

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use